These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3808000)

  • 41. Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Holvay E
    Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240
    [No Abstract]   [Full Text] [Related]  

  • 42. Porphyria cutanea tarda associated with chronic renal disease and hemodialysis.
    Poh-Fitzpatrick MB; Masullo AS; Grossman ME
    Arch Dermatol; 1980 Feb; 116(2):191-5. PubMed ID: 7356350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of late cutaneous porphyrias with iron chelating agents (EDTA, Desferral)].
    Thivolet J; Bondet P; Perrot H; Moene Y
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(3):388-91. PubMed ID: 4965024
    [No Abstract]   [Full Text] [Related]  

  • 44. Delayed onset of overt porphyria cutanea tarda in a patient on long-term haemodialysis. A case report.
    King J; Day RS; Milne FJ; Bezwoda WR; Viljoen JD; Kramer S
    S Afr Med J; 1983 May; 63(19):743-6. PubMed ID: 6845091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effectiveness of UDPG in the treatment of porphyria cutanea tarda. Preliminary findings].
    Okolicsanyi L; Orlando R; Busnardo F; Naccarato R; Veller-Fornasa C; Polin R
    Clin Ter; 1980 Sep; 94(6):687-94. PubMed ID: 7460503
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
    Holvay E
    Orv Hetil; 1981 Jul; 122(30):1839-42. PubMed ID: 7301351
    [No Abstract]   [Full Text] [Related]  

  • 47. Healing by second intention in porphyria cutanea tarda.
    Frumkin A; Matlock MS
    J Dermatol Surg Oncol; 1987 Nov; 13(11):1158, 1161. PubMed ID: 3668058
    [No Abstract]   [Full Text] [Related]  

  • 48. Porphyria cutanea tarda in a haemodialysed patient.
    Topi GC; Alessandro GL; Cancarini GC; De Costanza F; Griso D; Ravelli M
    Br J Dermatol; 1981 May; 104(5):579-80. PubMed ID: 7236518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Quantitative determination of urinary porphyrins using Rimington's and Sveinsson's technic and experience in the therapy of porphyria cutanea tarda using Desferal CIBA].
    Votruba M; Nozicková M; Pazderka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1969; 12(3):313-9. PubMed ID: 5265982
    [No Abstract]   [Full Text] [Related]  

  • 50. Porphyria cutanea tarda and bullous dermatoses associated with chronic renal failure: a review.
    Goldsman CI; Taylor JS
    Cleve Clin Q; 1983; 50(2):151-61. PubMed ID: 6357544
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical studies of the treatment of porphyria cutanea tarda with antitoxic fraction of the liver and cyanocobalamin].
    Valenzano L
    Minerva Med; 1967 Oct; 58(85):3633-5. PubMed ID: 6061469
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
    Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
    [No Abstract]   [Full Text] [Related]  

  • 54. [Results of the therapy of porphyria cutanea tarda based on urine alkalization].
    Resl V
    Cesk Dermatol; 1971 Dec; 46(6):249-52. PubMed ID: 5135264
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 56. [Detection of pseudo-porphyria cutanea tarda in 100 hemodialyzed patients (author's transl)].
    Griffon-Euvrard S; Thivolet J; Laurent G; Calemard E; Gaillemin J; Perrot H; Ortonne JP
    Dermatologica; 1977; 155(4):193-9. PubMed ID: 902828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pseudoporphyria cutanea tarda in hemodialysis patients].
    Thivolet J
    Hautarzt; 1979 Mar; 30(3):154-7. PubMed ID: 437971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bullous photo-onycholysis during pseudo-porphyria due to hemodialysis].
    Guillaud V; Moulin G; Bonnefoy M; Cognat T; Balme B; Barrut D
    Ann Dermatol Venereol; 1990; 117(10):723-5. PubMed ID: 2073064
    [No Abstract]   [Full Text] [Related]  

  • 60. Porphyria Cutanea tarda in Missouri.
    Anderson PC
    Mo Med; 1981 Jun; 78(6):299-302. PubMed ID: 7254176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.